BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts (Q33864374)

29 July 2017

BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts (English)

1 reference

29 July 2017

1 reference

Aimee L Lucas

1

1 reference

29 July 2017

Laura E Frado

2

1 reference

29 July 2017

Caroline Hwang

3

1 reference

29 July 2017

Sheila Kumar

4

1 reference

29 July 2017

Lauren G Khanna

5

1 reference

29 July 2017

Elana J Levinson

6

1 reference

29 July 2017

John A Chabot

7

1 reference

29 July 2017

Wendy K Chung

8

1 reference

29 July 2017

Harold Frucht

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

15 April 2014

1 reference

29 July 2017

1 reference

29 July 2017

120

1 reference

29 July 2017

13

1 reference

29 July 2017

1960-1967

1 reference

High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Risk of pancreatic cancer in families with Lynch syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Absence of germline BRCA1 mutations in familial pancreatic cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Pancreatic cancer and the FAMMM syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Cancer Incidence in BRCA1 mutation carriers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Very high risk of cancer in familial Peutz-Jeghers syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.

5 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28662

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28662

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5494829

Germline BRCA1 mutations predispose to pancreatic adenocarcinoma

29 October 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28662

Familial pancreatic cancer

21 January 2018

1 reference

12 December 2020

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer

1 reference

12 December 2020

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics

1 reference

12 December 2020

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden)

1 reference

12 December 2020

The prevalence of BRCA2 mutations in familial pancreatic cancer

1 reference

12 December 2020

Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer

1 reference

12 December 2020

Head and neck squamous cell carcinoma in FAMMM syndrome

1 reference

12 December 2020

Familial melanoma, pancreatic cancer and germline CDKN2A mutations

1 reference

12 December 2020

BRCA2 germline mutations in familial pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28662

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CNCR.28662

1 reference

29 July 2017

1 reference

29 July 2017

1 reference